7.20
Passage Bio Inc (PASG) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Research and Development |
24.85%
5.814
|
7.737 | - | - | - |
| Operating Income/Loss |
37.21%
-10.33
|
-16.46 | -14.27 | -20.70 | -17.38 |
| Income/Loss From Continuing Operations Before Tax |
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
| Income/Loss From Continuing Operations After Tax |
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
|
|
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.90%
3.1689
|
62.11 | 0.4845 | 61.76 | 61.68 |
| Diluted Average Shares |
94.90%
3.1689
|
62.11 | 0.4845 | 61.76 | 61.68 |
| Basic Earnings Per Share |
1,084%
-2.96
|
-0.25 | -0.20 | -0.31 | -0.26 |
| Diluted Earnings Per Share |
1,084%
-2.96
|
-0.25 | -0.20 | -0.31 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):